Risk Factors for Progressive Disease After Immune Checkpoint Inhibitor Therapy in Head and Neck Squamous Cell Carcinoma.
Jang SY, Lee YG, Chun SH, Park JH, Park KU, Chang H, Lee KW, Kim HR, Shin SH, An HJ, Lee KE, Hwang IG, Ahn MJ, Kim SB, Keam B.
Jang SY, et al. Among authors: lee ke, lee kw.
Head Neck. 2025 Jan 21. doi: 10.1002/hed.28071. Online ahead of print.
Head Neck. 2025.
PMID: 39835419